Home » Medical Pharmaceuticals

Tag: Medical Pharmaceuticals

Post
Stericycle President and CEO Cindy J. Miller Wins 2023 Gold Stevie® Award for Women in Business

Stericycle President and CEO Cindy J. Miller Wins 2023 Gold Stevie® Award for Women in Business

Miller is Stericycle’s Third C-Suite Executive to Win a Stevie® Award This Year BANNOCKBURN, Ill., Nov. 14, 2023 /PRNewswire/ — Stericycle, Inc. (Nasdaq: SRCL) a leading provider of regulated medical waste management and secure information destruction solutions, today announced that Cindy J. Miller, president and chief executive officer, has won the Gold Stevie® Award for Women...

Post
Actinium Appoints Lynn Bodarky as Chief Business Officer

Actinium Appoints Lynn Bodarky as Chief Business Officer

–       Senior leader with proven track record of executing business development and licensing transactions totaling $5 billion at multinational pharmaceutical and biotechnology companies NEW YORK, Nov. 3, 2023 /PRNewswire/ — Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that Lynn Bodarky has been...

Post
B. Braun of America Appoints Two Global Healthcare Leaders to its Board of Directors

B. Braun of America Appoints Two Global Healthcare Leaders to its Board of Directors

Dr. Dorothee Bartels Brings Extensive Experience in Pharmacoepidemiology, Big Data Analytics and Public HealthMichael Reitermann has Broad Background in Driving Technological Change and Innovation BETHLEHEM, Pa., Oct. 27, 2023 /PRNewswire/ — B. Braun of America Inc., a leader in smart infusion therapy and pain management, today announced the appointment of two new members to the...

Post
Gene Technology Light Up the Future – Opening of the International Conference of Genomics on Eye 2023

Gene Technology Light Up the Future – Opening of the International Conference of Genomics on Eye 2023

SHENYANG, China, Oct. 21, 2023 /PRNewswire/ — The International Conference of Genomics on Eye 2023 (the “6th ICG Eye”) embraced its grand opening in Shenyang on 14th-15th October. The conference, hosted by the Shenyang Municipal People’s Government, organized by the Shenyang Bureau of Science and Technical, Government of Hunnan District, Shenyang and He Eye Specialist Hospital,...

Post
Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

Government of Serbia and Ginkgo Bioworks Announce Bioeconomy Collaboration in BIO4 Campus

BELGRADE, Serbia and BOSTON, Oct. 19, 2023 /PRNewswire/ — Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, and the Government of Serbia today announced that they have entered into a Memorandum of Understanding (“MoU”) with the intent of collaborating in support of Serbia’s bioeconomy vision. Government of Serbia and...

Post
Subtle Medical Achieves Exponential International Growth, Doubling Business in the Last 12 Months

Subtle Medical Achieves Exponential International Growth, Doubling Business in the Last 12 Months

Subtle reports the rapid global expansion of their AI software for faster medical imaging and better patient care MENLO PARK, Calif., Oct. 19, 2023 /PRNewswire/ — Subtle Medical, a leading provider of artificial intelligence (AI)-powered technology for faster medical imaging, announced its remarkable growth, having doubled its business both in the US and internationally in...

Post
Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World

Ceres Nanosciences and Ginkgo Bioworks Partner to Bring Pathogen Monitoring Capabilities to Labs Around the World

MANASSAS, Va. and BOSTON, Sept. 12, 2023 /PRNewswire/ — Ceres Nanosciences, a global leader in developing wastewater testing methods based on its Nanotrap® technology, and Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that they are partnering to bring pathogen monitoring capabilities to laboratories around the...

Post
Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson’s Disease and Movement Disorders

Theravance Biopharma to Present New Ampreloxetine Data at the 2023 International Congress of Parkinson’s Disease and Movement Disorders

DUBLIN, Aug. 28, 2023 /PRNewswire/ — Theravance Biopharma, Inc. (“Theravance Biopharma” or the “Company”) (NASDAQ: TBPH) today announced new ampreloxetine data in neurogenic orthostatic hypotension (nOH) will be presented at the 2023 International Congress of Parkinson’s Disease and Movement Disorders (MDS), taking place August 27-31, 2023, in Copenhagen, Denmark. “The data presented at this meeting continue...

Post
Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA

Aurora Cannabis Announces Fiscal 2024 First Quarter Results, and Delivers Record Positive Adjusted EBITDA

Achieves Quarterly Net Revenue1 of $75.1 Million; Strong YoY Growth Across All Business Units; Global Medical Cannabis +14%, Consumer Cannabis +5%, Plant Propagation +12% Delivers Third Sequential Quarter of Positive Adjusted EBITDA1, Supported by Bevo’s Record Quarterly Revenue Cash Used in Operating Activities Reduced by $15.5 Million YoY, Re-Affirms Target of Positive Free Cash Flow...

Post
Pacific Dental Services Marks 40th International Service Trip and $11 Million in Donated Dentistry Around The World

Pacific Dental Services Marks 40th International Service Trip and $11 Million in Donated Dentistry Around The World

PDS-supported clinicians and volunteers traveled to Guatemala for its 40th international service trip. IRVINE, Calif., Aug. 10, 2023 /PRNewswire/ —Pacific Dental Services® (PDS), one of the nation’s leading dental and medical support organizations, achieved a significant milestone in July 2023 by completing its 40th international service trip to provide vital dental care to patients in need....

Post
Ginkgo Bioworks Reports Second Quarter 2023 Financial Results

Ginkgo Bioworks Reports Second Quarter 2023 Financial Results

Ginkgo added 21 new Cell Programs to the Foundry platform in Q2 2023 Highlighted continued success selling into large established biotech R&D organizations with recently expanded relationships with Sumitomo, Novo Nordisk, and Merck Ginkgo ended Q2 2023 with approximately $1.1 billion in cash and cash equivalents, providing a strong multi-year runway as Ginkgo continues to...

Post
InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth

InMode Reports Second Quarter 2023 Financial Results; Record Quarterly Revenue of $136.1M Represents 20% Year-Over-Year Growth

YOKNEAM, Israel, July 27, 2023 /PRNewswire/ — InMode Ltd. (Nasdaq: INMD) (“InMode”), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the second quarter ended June 30, 2023. Second Quarter 2023 Highlights: Record quarterly revenue of $136.1 million, an increase of 20% compared to the second quarter of 2022. InMode’s...

  • 1
  • 2